Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy.
about
Intermedin in the paraventricular nucleus attenuates cardiac sympathetic afferent reflex in chronic heart failure rats.Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation.miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activityLong Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy.Prognostic Value of Plasma Intermedin Level in Patients With Non-ST-Segment Elevation Acute Coronary SyndromeThe role of autophagy in cardiac hypertrophy.Intermedin1-53 Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient Mice.Intermedin1‑53 enhances angiogenesis and attenuates adverse remodeling following myocardial infarction by activating AMP‑activated protein kinaseIntermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease.Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases.Intermedin improves cardiac function and sympathetic neural remodeling in a rat model of post myocardial infarction heart failure.Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy.SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms.2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.A-Kinase Anchoring Protein-Lbc: A Molecular Scaffold Involved in Cardiac Protection.HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy.Integrated microRNA-mRNA analysis of coronary artery disease.Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.Effects of intermedin on dorsal root ganglia in the transmission of neuropathic pain in chronic constriction injury rats.
P2860
Q31157932-59237993-01C9-46E5-B69A-B9F741240657Q33684305-3E008822-00B9-4BB0-9471-E62FADE11E70Q35146756-234AD1CE-38BC-4D9B-BF32-4F758189854BQ35991214-E50F5C5C-B043-4B4F-9B8A-53A9AC5163F8Q36838073-B43257A4-ED66-4BEB-8E6B-974C1EC5750AQ37020052-8C56ED58-B175-462C-8A15-EC6246920809Q37420506-E37D4092-E44E-4A95-B002-D07D4EC4E7E0Q37720254-57DE9EB2-2E74-410C-97A2-A064E31A5727Q38238024-E08A4382-8280-462A-B20D-248ECB755DA0Q39240550-761819AE-C683-4BAE-9B88-46D3CA41890FQ39424665-0431F291-4C55-4F74-943B-79C83680C7EAQ42347165-5F72ABC9-3BC4-470E-8568-74F8C57CE60FQ42922923-C8FD2A81-7E6D-4C39-9E16-9100601853F6Q46608419-A42A75E4-182A-4015-AD7E-E5D34453FD18Q47388691-E13F90CE-B6D3-4B14-80C2-9222E997B54BQ50117582-7E75D2A2-D6CC-496C-BFEF-37AAC8965231Q50790812-E41FC7D5-454A-4CBD-BCBB-0D22F495683FQ51080450-44E98A95-7F33-4072-A9DF-FE87102C13B6Q53095486-B47058CD-9D6E-44E5-98EE-53A3AD697478Q54163600-5D6B1666-C51A-4A82-9383-6D0C8350BF3D
P2860
Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intermedin suppresses pressure ...... rough activation of autophagy.
@ast
Intermedin suppresses pressure ...... rough activation of autophagy.
@en
type
label
Intermedin suppresses pressure ...... rough activation of autophagy.
@ast
Intermedin suppresses pressure ...... rough activation of autophagy.
@en
prefLabel
Intermedin suppresses pressure ...... rough activation of autophagy.
@ast
Intermedin suppresses pressure ...... rough activation of autophagy.
@en
P2093
P2860
P1433
P1476
Intermedin suppresses pressure ...... rough activation of autophagy.
@en
P2093
Chaoshu Tang
Huali Chen
Jiaxiang Chen
Mingming Tong
Xiaoxiao Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0064757
P407
P577
2013-05-29T00:00:00Z